Shanghai INT Medical Instruments Analysis in March (2026)

Shanghai INT Medical...

SEHK:1501

HK$ 32,98

HK$-0,12 (-0,36%)

32,98 HK$

HK$-0,12 (-0,36%)

End-of-day quote: 03/31/2026

Shanghai INT Medical Instruments Stock Value

Analysts currently give SEHK:1501 a rating of sf_Data Unavailable.

Shanghai INT Medical Instruments Company Info

EPS Growth 5Y

6,10%

Market Cap

HK$6,93 B

Long-Term Debt

HK$0,00 B

Quarterly earnings

05/19/2026 (E)

Dividend

HK$0,26

Dividend Yield

0,79%

Founded

2006

Industry

Health Care

Country

China

Website

Shanghai INT Medical Instruments

ISIN Number

CNE100003NH7

Website

http://www.int-medical.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Shanghai INT Medical Instruments’s Price Target has risen from HK$34,54 to HK$34,54 - a 0,00% increase. One analysts predict that Shanghai INT Medical Instruments’s share price will fall in the coming year, reaching HK$0,00. This would represent a decrease of -100,00%.

Top growth stocks in the health care sector (5Y.)

What does Shanghai INT Medical Instruments do?

Shanghai INT Medical Instruments Co., Ltd. is a prominent entity in the medical instrument industry, specifically known for its extensive range of medical equipment and devices. The company's primary operations span the design, development, manufacture, and distribution of innovative medical instruments. These instruments are crucial in various healthcare settings, assisting medical professionals in delivering quality patient care. The company prides itself on adhering to high standards of qual...

The company prides itself on adhering to high standards of quality and compliance with international regulations in the healthcare sector. The company has invested substantially in research and development, ensuring that its product offerings are at the forefront of technological advancements. The commitment to innovation plays a vital role in its ability to meet the evolving demands of healthcare providers worldwide.

Additionally, the company engages in a rigorous supply chain management system, ensuring its products not only meet medical efficacy but are also produced through sustainable practices. Environmental stewardship is a cornerstone of its operations, reflecting a commitment to minimizing the ecological footprint associated with medical manufacturing. This aligns with the company's aim to contribute positively to the healthcare ecosystem while maintaining a sustainable business model.

Business Segments

The Business segment of the company includes:

The company operates through several distinct business segments, each focusing on specific categories of medical instruments and devices. These segments comprise manufacturing and sales of medical syringes, infusion sets, and other disposable medical products that cater to hospital and clinical environments. The company has developed these product segments to not only fulfill market needs but also to enhance its operational efficiencies.

The production segment emphasizes continuous improvement in manufacturing processes and technologies. The company employs advanced automation and craftsmanship to ensure that its product offerings are consistently reliable and of high quality. Product safety and efficacy are critical considerations during the manufacturing process, with strict quality assurance measures in place to uphold these standards.

Furthermore, the company has ventured into a sustainable supply chain model. The company collaborates with suppliers who share a commitment to sustainability and ethical practices, focusing on minimizing waste and ensuring that all components meet rigorous safety standards. This initiative is pivotal in not only supporting the company's ethical stance but also in satisfying increasing consumer demand for environmentally responsible products.

Products and Services

The Products and Services of the company includes:

The company offers an extensive range of products designed to meet the needs of the healthcare sector efficiently. The company primarily specializes in disposable medical devices and instruments, which include various types of medical syringes, infusion sets, and needles. Each product category is engineered for safety and effectiveness, ensuring that healthcare professionals can rely on them during treatments.

The product line includes high-precision syringes utilized for injectable medications. These syringes are designed to enhance accuracy while reducing the risk of contamination, thereby safeguarding patient health. Infusion sets, another key product, are developed to facilitate intravenous therapies within clinical settings. The company ensures that these devices are not only user-friendly but also equipped with features like anti-reflux technology to optimize patient care and safety.

Additionally, the company invests in producing specialized instruments that cater to niche medical needs, such as surgical tools and diagnostic aids. By diversifying its offerings, the company remains adaptable and responsive to shifting market demands and technological advancements.

Beyond product offerings, the company also emphasizes training and consultancy services to its customers, aiding healthcare facilities in optimizing their utilization of medical devices. This dual approach ensures that the company builds strong relationships within the medical community while positioning itself as a knowledgeable partner in healthcare solutions.

Geographical Markets Served

The company operates in various geographical markets, providing medical instruments worldwide. The company has strategically positioned itself to address the needs of emerging markets by expanding its reach beyond domestic boundaries into regions with growing healthcare needs. This expansion allows the company to capture new market opportunities and promote global healthcare improvements.

In addition to serving the domestic Chinese market, the company has established a strong presence in Southeast Asia, Europe, and North America. Tailoring products to meet regional healthcare regulations and cultural expectations has been fundamental in successfully penetrating these diverse markets. By understanding each geographical market's unique needs, the company enhances its service delivery and product applicability.

Customers

The company serves a diverse customer base within the healthcare sector, which includes hospitals, clinics, and various medical facilities. The clientele comprises both domestic and international entities, highlighting the company's extensive reach.

The company engages with several categories of customers, from large institutions requiring bulk procurement of medical instruments to smaller clinics needing specialized devices. This diversified customer approach allows the company to tailor its offerings to meet various operational needs and scale.

Sales and Marketing

The company employs a multifaceted sales and marketing approach to reach its diverse customer base effectively. The company utilizes both direct sales teams and established distribution channels to facilitate outreach.

Direct sales teams are equipped with strong industry knowledge, enabling them to address customer-specific needs and provide tailored solutions. Engagement with healthcare professionals through sponsorship of medical conferences and workshops further enhances brand visibility and trust among target markets.

Additionally, the company has invested in digital marketing strategies, utilizing online platforms to reach a broader audience and generate leads. This digital presence is complemented by partnerships with distributors and wholesalers, ensuring that products are widely available across geographical locations.

History

Shanghai INT Medical Instruments Co., Ltd. was formed in 2006 and incorporated in 2015.

Shanghai INT Medical Instruments Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Medical Devices:** 60% **Diagnostic Products:** 25% **Hospital Supplies:** 15% **Top 3 Markets:** **China:** 45% **USA:** 30% **Europe:** 15% Shanghai INT Medical Instruments Co., Ltd. generates the majority of its revenue from the manufacturing and sale of medical devices, which a...

At which locations are the company’s products manufactured?

**Production Sites:** Shanghai, China Shanghai INT Medical Instruments Co., Ltd. mainly produces its products in Shanghai, China. This is a strategically chosen location, as Shanghai is considered one of China's leading economic and technological hubs. The proximity to key supply chains and a...

What strategy does Shanghai INT Medical Instruments pursue for future growth?

**Revenue Growth:** Estimated 10-12% annually (2026) Shanghai INT Medical Instruments Co., Ltd. is focusing on expanding into international markets, particularly in Southeast Asia and Europe. This strategy aims to reduce dependence on the domestic market and tap into new sources of revenue. The co...

Which raw materials are imported and from which countries?

**Main raw materials:** High-quality stainless steel, plastic components, electronic parts **Countries of origin:** - **Stainless steel:** Japan, South Korea - **Plastic components:** Germany, USA - **Electronic parts:** Taiwan, China Shanghai INT Medical Instruments Co., Ltd. imports a variety of...

How strong is the company’s competitive advantage?

**Market share in China:** 8% (2025, estimated) **Research & Development expenses:** 12% of revenue (2025) **Industry comparison R&D:** Average 10% of revenue Shanghai INT Medical Instruments Co., Ltd. has a significant competitive advantage due to its strong position in the Chinese m...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 48% (estimated, 2026) **Insider Buys/Sells:** No significant transactions in the last year (2026) The institutional investor share of Shanghai INT Medical Instruments Co., Ltd. is estimated to be around 48%. This suggests that almost half of the shares are held b...

What percentage market share does Shanghai INT Medical Instruments have?

**Market share of Shanghai INT Medical Instruments Co., Ltd.:** 8% (2026, estimated) **Top competitors and their market shares:** 1. **Medtronic plc:** 15% 2. **Johnson & Johnson:** 12% 3. **Siemens Healthineers AG:** 10% 4. **GE Healthcare:** 9% 5. **Shanghai INT Medical Instruments Co., Ltd.:...

Is Shanghai INT Medical Instruments stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **R&D Expenses:** 12% of revenue (2025) **Market Share in China:** 18% (2025) Shanghai INT Medical Instruments Co., Ltd. shows a solid revenue growth of 8.5% in 2025, indicating strong demand for their medical devices and instruments. The company is also investin...

Does Shanghai INT Medical Instruments pay a dividend – and how reliable is the payout?

**Dividend Yield:** 2.5% (estimated for 2026) **Dividend History:** Continuous payout since 2020 Shanghai INT Medical Instruments Co., Ltd. has been paying dividends in recent years and demonstrates a relatively stable dividend policy. The estimated dividend yield of 2.5% in 2026 suggests that...

New support ticket

Explore

Shanghai INT Medical Instruments Stock Value

Shanghai INT Medical Instruments Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Shanghai INT Medical Instruments do?

Shanghai INT Medical Instruments Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Shanghai INT Medical Instruments Stock Value

Shanghai INT Medical Instruments Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Shanghai INT Medical Instruments do?

Shanghai INT Medical Instruments Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.